Kareen Aguihap
Family · Houston, TXNPI 1770045510
Payments from drug & device makers
Across 347 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Sanofi$913
- Takeda Pharmaceuticals U.S.A., Inc.$659
- Kaleo, Inc.$461
- Grifols USA, LLC$447
- plus $3K from 27 others
What the payments were for
- Consulting fees$170%
- Food & beverage$7,467100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 54 | $1,158 |
| GSK | 68 | $1,144 |
| Sanofi | 35 | $913 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $659 |
| Kaleo, Inc. | 20 | $461 |
| Grifols USA, LLC | 28 | $447 |
| Novartis | 16 | $339 |
| Octapharma USA, Inc. | 5 | $315 |
| Regeneron Healthcare Solutions, Inc. | 10 | $256 |
| CSL Behring | 11 | $255 |
| Optinose US, Inc. | 12 | $245 |
| Incyte Corporation | 8 | $184 |
| Inspire Medical Systems, Inc. | 2 | $158 |
| Pfizer | 8 | $139 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $134 |
| Teva Pharmaceuticals USA, Inc. | 5 | $118 |
| Medtronic | 4 | $92 |
| Amgen | 4 | $73 |
| Boehringer Ingelheim | 3 | $71 |
| Pharming Healthcare, Inc. | 2 | $45 |
| Organon | 3 | $37 |
| Ionis Pharmaceuticals, Inc. | 1 | $35 |
| Biocryst US Sales Co., LLC | 2 | $30 |
| LEO Pharma Inc. | 1 | $26 |
| Alk-abello, Inc | 2 | $24 |
| Mylan Specialty L.p. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Merck | 1 | $17 |
| ADMA Biomanufacturing LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,498 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 13 | $41,792 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $17,169 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $16,706 |
| Epinephrine | 18 | $2,551 |
| Fluticasone Propionate | 82 | $1,579 |
| Azelastine Hcl | 41 | $1,111 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,062 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,040 |
| Montelukast Sodium | 60 | $777 |
| Ipratropium Bromide | 14 | $651 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $323 |
| Levocetirizine Dihydrochloride | 22 | $237 |
| Methylprednisolone | 28 | $186 |
| Clindamycin Hcl | 11 | $133 |
| Azithromycin | 27 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $1,144 | $33,87543 claims |
| Hikma Pharmaceuticals USAEpinephrine | $21 | $2,55118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in Houston
- Lashonda CraneHouston$3.4M
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- David WeirDallas$959K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.